
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-03-18 | Sheri Biggs(R-SC03) | house | Sale | $1,001 - $15,000 |
No financial data available for SHTDY.
Company may not file with SEC or CIK is unresolved.
Sinopharm Explores Noninvasive Glucose Monitoring To Deepen China Diabetes Role
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities
Dodge & Cox Emerging Markets Stock Fund Q2 2025 Shareholder Letter
Lazard Retirement Emerging Markets Equity Portfolio Q1 2025 Commentary
Lazard Emerging Markets Equity Portfolio Q1 2025 Commentary
Sinopharm Group: Mixed Read-Throughs From Peer Disclosures And Management Guidance
Allspring Emerging Markets Equity Income Fund Q4 2024 Commentary
Sinopharm Group: The Focus Is On Working Capital And Profitability
Sinopharm Group: External Headwinds And Re-Rating Drivers Draw Attention
Pneumonia outbreak in China is no reason for alarm: WHO